Keith T. Sowards

Keith T. Sowards

Auto-generated profile, based on publicly available information

Keith T. Sowards

Department of Radiation Oncology, University of Louisville School of Medicine, Louisville, KY, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2024 in IEEE Robotics and Automation Letters
Verified
Journal Article
Closed access
PKPejman Kheradmand
Pejman Kheradmand
BMBehnam Moradkhani
Behnam Moradkhani
HJHarshith Jella
Harshith Jella
KSKeith Sowards
Keith Sowards
SSScott R. Silva
Scott R. Silva
YCYash Chitalia
Yash Chitalia
Interstitial brachytherapy requires up to 20 straight needles to surround and irradiate deep-seated tumors, but may offer sub-optimal radiation dosage in cases of advanced cancers. A steerable stylet can be used to guide the needle within the tissue, improving procedure accuracy and reducing the number of needles required for each operation. This work introduces the design of a novel tendon-assisted magnetically steered (TAMS) robotic stylet to steer commercially available brachytherapy needles. The dual-actuation modality (magnetic and tendon-driven) allows for increased bending compliance while retaining axial rigidity at extremely small diameters (OD: 1.4 mm), key properties for steering hollow needles from within their lumen. We also develop a two-tube Cosserat rod model that estimates the behavior of the TAMS robot and needle assembly under actuation from tendons, external magnetic fields, and finally combined magnet+tendon forces. We validate our model in free space and demonstrate the capability of the TAMS robot and dual-actuation modalities to steer brachytherapy needles to high curvatures inside phantom tissue.

14 May 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
APAndres Portocarrero-Bonifaz
Andres Portocarrero-Bonifaz
SSSalman Syed
Salman Syed
MKMaxwell Kassel
Maxwell Kassel
GMGrant W. McKenzie
Grant W. McKenzie
VSVishwa M. Shah
Vishwa M. Shah
SSScott R. Silva
Scott R. Silva
Background: Gynecological cancers are among the most prevalent cancers in women worldwide. Brachytherapy, often used as a boost to external beam radiotherapy, is integral to treatment. Advances in computation, algorithms, and data availability have popularized the use of machine learning to predict patient outcomes. Recent studies have applied models such as logistic regression, support vector machines, and deep learning networks to predict specific toxicities in patients who have undergone brachytherapy. Objective: To develop and compare machine learning models for predicting grade 3 or higher toxicities in gynecological cancer patients treated with high dose rate (HDR) brachytherapy, aiming to contribute to personalized radiation treatments. Methods: A retrospective analysis was performed on gynecological cancer patients who underwent HDR brachytherapy with Syed-Neblett or Tandem and Ovoid applicators from 2009 to 2023. After applying exclusion criteria, 233 patients were included in the analysis. Dosimetric variables for the high-risk clinical target volume (HR-CTV) and organs at risk, along with tumor, patient, and toxicity data, were collected and compared between groups with and without grade 3 or higher toxicities using statistical tests. Seven supervised classification machine learning models (Logistic Regression, Random Forest, K-Nearest Neighbors, Support Vector Machines, Gaussian Naive Bayes, Multi-Layer Perceptron Neural Networks, and XGBoost) were constructed and evaluated. The training process involved sequential feature selection (SFS) when appropriate, followed by hyperparameter tuning. Final model performance was characterized using a 25% withheld test dataset. Results: The top three ranking models were Support Vector Machines, Random Forest, and Logistic Regression, with F1 testing scores of 0.63, 0.57, and 0.52; normMCC testing scores of 0.75, 0.77, and 0.71; and accuracy testing scores of 0.80, 0.85, and 0.81, respectively. The SFS algorithm selected 10 features for the highest-ranking model. In traditional statistical analysis, HR-CTV volume, Charlson Comorbidity Index, Length of Follow-Up, and D2cc - Rectum differed significantly between groups with and without grade 3 or higher toxicities. Conclusions: Machine learning models were developed to predict grade 3 or higher toxicities, achieving satisfactory performance. Machine learning presents a novel solution to creating multivariable models for personalized radiation therapy.

4 June 2026 in Journal of Medical Robotics Research
Verified
Journal Article
Closed access
PDF file
PKPejman Kheradmand
Pejman Kheradmand
KYKent K. Yamamoto
Kent K. Yamamoto
EWEmma Webster
Emma Webster
KSKeith Sowards
Keith Sowards
GHGianna Hatheway
Gianna Hatheway
YCYash Chitalia
Yash Chitalia

6 October 2024 in medRxiv
Verified
Preprint
Open access
PDF file
APAndres Portocarrero-Bonifaz
Andres Portocarrero-Bonifaz
SSSalman Syed
Salman Syed
MKMaxwell Kassel
Maxwell Kassel
GMGrant W. McKenzie
Grant W. McKenzie
VSVishwa M. Shah
Vishwa M. Shah
SSScott R. Silva
Scott R. Silva
Background Gynecological cancers are among the most prevalent cancers in women worldwide. Brachytherapy, often used as a boost to external beam radiotherapy, is integral to treatment. Advances in computation, algorithms, and data availability have popularized machine learning. Objective To develop and compare machine learning models for predicting grade 3 or higher toxicities in gynecological cancer patients treated with high dose rate (HDR) brachytherapy, aiming to contribute to personalized radiation treatments. Methods A retrospective analysis on gynecological cancer patients who underwent HDR brachytherapy with Syed-Neblett or Tandem and Ovoid applicators from 2009 to 2023. After exclusions, 233 patients were included. Dosimetric variables for the high-risk clinical target volume (HR-CTV) and organs at risk, along with tumor, patient, and toxicity data, were collected and compared between groups with and without grade 3 or higher toxicities using statistical tests. Six supervised classification machine learning models (Logistic Regression, Random Forest, K-Nearest Neighbors, Support Vector Machines, Gaussian Naive Bayes, and Multi-Layer Perceptron Neural Networks) were constructed and evaluated. The construction process involved sequential feature selection (SFS) when appropriate, followed by hyperparameter tuning. Final model performance was characterized using a 25% withheld test dataset. Results The top three ranking models were Support Vector Machines, Random Forest, and Logistic Regression, with F1 testing scores of 0.63, 0.57, and 0.52; normMCC testing scores of 0.75, 0.77, and 0.71; and accuracy testing scores of 0.80, 0.85, and 0.81, respectively. The SFS algorithm selected 10 features for the highest-ranking model. In traditional statistical analysis, HR-CTV volume, Charlson Comorbidity Index, Length of Follow-Up, and D2cc - Rectum differed significantly between groups with and without grade 3 or higher toxicities. Conclusions Machine learning models were developed to predict grade 3 or higher toxicities, achieving satisfactory performance. Machine learning presents a novel solution to creating multivariable models for personalized radiation therapy care.